LM Advisors LLC reduced its stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 29.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 60,555 shares of the company’s stock after selling 24,728 shares during the quarter. LM Advisors LLC’s holdings in BlackRock Health Sciences Term Trust were worth $872,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of BMEZ. Brown Brothers Harriman & Co. bought a new position in shares of BlackRock Health Sciences Term Trust during the third quarter worth approximately $32,000. K2 Principal Fund L.P. bought a new position in BlackRock Health Sciences Term Trust during the 3rd quarter worth $158,000. Virtu Financial LLC acquired a new stake in shares of BlackRock Health Sciences Term Trust during the fourth quarter worth $206,000. Jane Street Group LLC bought a new stake in shares of BlackRock Health Sciences Term Trust in the third quarter valued at about $357,000. Finally, Corient Private Wealth LLC grew its stake in shares of BlackRock Health Sciences Term Trust by 24.9% in the fourth quarter. Corient Private Wealth LLC now owns 26,225 shares of the company’s stock valued at $378,000 after acquiring an additional 5,224 shares in the last quarter.
BlackRock Health Sciences Term Trust Stock Performance
Shares of BlackRock Health Sciences Term Trust stock opened at $15.07 on Thursday. BlackRock Health Sciences Term Trust has a twelve month low of $14.27 and a twelve month high of $16.75. The company has a 50-day simple moving average of $15.77 and a two-hundred day simple moving average of $15.60.
BlackRock Health Sciences Term Trust Dividend Announcement
BlackRock Health Sciences Term Trust Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Recommended Stories
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Financial Services Stocks Investing
- Energy Transfer: Powering Data With Dividends and Diversification
- Which Wall Street Analysts are the Most Accurate?
- Qualcomm Stock Is Coiling for a Breakout
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.